Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside upbeat for current year, despite uncertain outlook
15 Oct 2020 - Countryside Properties Profit To Fall; Post-Lockdown Trade Encouraging
15 Oct 2020 - UK BROKER RATINGS SUMMARY: Barclays Initiates Housebuilder Ratings
9 Oct 2020 - UK Earnings, Trading Statements Calendar - Next 7 Days
8 Oct 2020 - Monday broker round-up
28 Sep 2020 - Countryside Properties To Build New London Homes For New Sigma JV
22 Sep 2020 - Countryside launches new London framework with Sigma Capital
22 Sep 2020 - Countryside Properties results delayed as Covid-19 impacts audit process
16 Sep 2020
Related News
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
WINNERS & LOSERS: Vodafone and easyJet jump on deal activity
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.
CSP.L News
Countryside upbeat for current year, despite uncertain outlook
(Sharecast News) - Countryside Properties insisted it was well positioned for current financial year on Thursday, despite the uncertain economic outlo...
Countryside Properties Profit To Fall; Post-Lockdown Trade Encouraging
Countryside Properties Profit To Fall; Post-Lockdown Trade Encouraging
UK BROKER RATINGS SUMMARY: Barclays Initiates Housebuilder Ratings
UK BROKER RATINGS SUMMARY: Barclays Initiates Housebuilder Ratings
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Monday broker round-up
(Sharecast News) - William Hill: RBC Capital Markets downgrades to sector perform with a target price of 300.0p.
Countryside Properties To Build New London Homes For New Sigma JV
Countryside Properties To Build New London Homes For New Sigma JV
Countryside launches new London framework with Sigma Capital
(Sharecast News) - Countryside Properties expanded its strategic relationship with private rental sector provider Sigma Capital, it announced on Tuesd...
Countryside Properties results delayed as Covid-19 impacts audit process
(Sharecast News) - Countryside Properties has pushed back the release of its full-year results, pinning the blame on the Covid-19 pandemic.
Follow the stocks
